Oracle has found itself in the line of fire as investors sound the alarm over its massive borrowing—and as broader concerns about artificial-intelligence spending rock the market.

In 2018, the VA signed a $10 billion contract with Cerner Corp. for a new electronic health record system, which has caused problems for veterans and staff since launching in Spokane in October 2020.

Oracle remains a Strong Buy with a $463 price target, despite rising debt and investor concerns over AI infrastructure exposure. ORCL's critical role in domestic AI infrastructure, especially through ...

Oracle is aggressively building out AI data centers, most notably for OpenAI under a massive multi-year deal The company's balance sheet is already loaded with debt, and more debt is being piled on to ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The shares surged 85% from April lows, hitting an ...

Oracle (ORCL) shares have decreased by 29.3% over the past 21 trading days. This recent decline signals renewed worries regarding stagnant cloud profit margins and the risks associated with AI ...

Oracle stock (NYSE: ORCL) has dropped approximately 30% in a month, wiping out billions in market capitalization and erasing substantial prior gains. This sharp decline aligns with past patterns, ...

Tepper's fund has beaten the market for decades, delivering exceptional returns along the way. Oracle has been extremely volatile in recent months. The company reported blowout earnings in September, ...

A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...